Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 22% ± 6% | |
| epithelial cell | 4 studies | 22% ± 5% | |
| endothelial cell of lymphatic vessel | 4 studies | 21% ± 3% | |
| transit amplifying cell | 3 studies | 32% ± 18% | |
| astrocyte | 3 studies | 31% ± 2% | |
| oligodendrocyte | 3 studies | 18% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 21% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 986.59 | 245 / 245 | 100% | 10.27 | 502 / 502 |
| brain | 100% | 550.08 | 2637 / 2642 | 99% | 11.74 | 701 / 705 |
| thymus | 100% | 904.38 | 653 / 653 | 99% | 9.81 | 600 / 605 |
| ovary | 100% | 1098.52 | 180 / 180 | 99% | 11.58 | 425 / 430 |
| breast | 100% | 897.66 | 459 / 459 | 97% | 16.49 | 1085 / 1118 |
| kidney | 100% | 615.62 | 89 / 89 | 96% | 7.40 | 868 / 901 |
| adrenal gland | 100% | 918.03 | 258 / 258 | 87% | 4.78 | 199 / 230 |
| bladder | 100% | 795.14 | 21 / 21 | 76% | 6.63 | 381 / 504 |
| pancreas | 99% | 410.52 | 325 / 328 | 72% | 3.70 | 128 / 178 |
| lung | 100% | 671.04 | 578 / 578 | 67% | 4.50 | 774 / 1155 |
| skin | 99% | 458.32 | 1795 / 1809 | 64% | 3.42 | 300 / 472 |
| stomach | 99% | 489.81 | 356 / 359 | 57% | 3.48 | 163 / 286 |
| uterus | 100% | 884.14 | 170 / 170 | 47% | 3.95 | 218 / 459 |
| intestine | 100% | 636.43 | 966 / 966 | 41% | 2.13 | 218 / 527 |
| esophagus | 100% | 506.22 | 1439 / 1445 | 41% | 2.74 | 75 / 183 |
| adipose | 100% | 685.13 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 970.35 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.46 | 1 / 1 |
| blood vessel | 100% | 498.88 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 346.30 | 843 / 861 | 0% | 0 | 0 / 0 |
| muscle | 79% | 156.79 | 637 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 79% | 4.23 | 23 / 29 |
| peripheral blood | 65% | 356.13 | 607 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 50% | 2.34 | 40 / 80 |
| liver | 14% | 21.95 | 32 / 226 | 30% | 1.60 | 120 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 20% | 0.62 | 9 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF43 |
| Protein name | Zinc finger protein 43 Zinc finger protein 43 (Zinc finger protein 39) (Zinc finger protein HTF6) (Zinc finger protein KOX27) |
| Synonyms | ZNF39 KOX27 ZNF39L1 |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | ENST00000598381.5 [P17038-2] M0R0T7 A0A0G2JQ90 ENST00000599906.5 A0A087WSW2 ENST00000624335.1 ENST00000595461.5 [P17038-2] M0QXI2 ENST00000624732.1 ENST00000623359.1 ENST00000598288.5 M0QYJ6 ENST00000354959.9 [P17038-1] M0R3D5 ENST00000357491.10 P17038 ENST00000593551.1 ENST00000596899.1 ENST00000623648.1 ENST00000594012.5 [P17038-2] |
